As there is also evidence for it being involved in liver fibrosis in mice [103] and of its expression increased in the PBC liver (with its soluble form raised in sera of patients with chronic liver diseases) [104], it is possible that TL1A will also increase response of liver MAIT cells to inflammatory cues, thereby accelerating liver fibrosis. Here, TNFSF15 is linked to Hepatic fibrosis.